PMCBNasdaq CM

PharmaCyte Biotech, Inc.

0.53−1.50%1d

Data as of Aug 24, 2026 · end-of-day snapshot

Volume signal tier
Alert levelinsufficient_liquidity

Tier and alert level are a summary. Unlock PMCB to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+0.17%, upReturn · 1w
−10.26%, downReturn · 1m
−30.92%, downReturn · 3m
−48.78%, downReturn · 1y
−65.23%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 34.

RSI (14)33.94, caution readingLower-neutral
MACD / signal-0.03 / -0.03, favorable readingAbove signal line
SMA 500.65, caution readingPrice below
SMA 2000.75, caution readingPrice below
EMA 200.56, caution readingPrice below
ADX (14)45.78Trending
+DI / −DI5.56 / 19.67, caution reading−DI leading
ATR (14)0.03, flagged reading6.4% of price — elevated daily swings
Stochastic %K19.44, flagged readingOversold zone
Bollinger bands (20)0.50 – 0.62Inside bands
ROC (10)-3.85, caution readingNegative over 10 sessions
Trend / momentum impulseMixedTrend and momentum disagree

Readings as of Aug 24, 2026 · end-of-day snapshot

Full analysis

What unlocking PMCB reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock PMCB: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get PMCB + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock PMCB